Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000631

Drug Information
NameRosiglitazone & metformin
CompanyGSK
IndicationType 2 diabetes ĘC extended releasePhase III completed    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C18H18N2O3/c1-10-12(7-8-17(21)22)11(2)19-16(10)9-14-13-5-3-4-6
-15(13)20-18(14)23/h3-6,9,19H,7-8H2,1-2H3,(H,20,23)(H,21,22)/b14-
9-
InChIKeyNHFDRBXTEDBWCZ-ZROIWOOFSA-N
Canonical SMILESCC1=C(NC(=C1CCC(=O)O)C)C=C2C3=CC=CC=C3NC2=O    
Isomeric SMILESCC1=C(NC(=C1CCC(=O)O)C)/C=C\2/C3=CC=CC=C3NC2=O
CAS NumberCAS 122320-73-4
FormulaC26H35ClN8O7S
PubChem Compound IDCID 5329099.
SuperDrug ATC IDA10BG02
ClinicalTrials.govNCT00499707;
TargetPPAR gammaAgonist[1]
Ref 1GSK. Product Development Pipeline. February 2009. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543